Clinical trial
Normal Saline Versus Betadine Use to Reduce the Incidence of Wound Infection in Cesarean
NCT03725748 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Normal Saline Versus Betadine Use to Reduce the Incidence of Wound Infection in Cesarean
- Lead sponsor
- Kasr El Aini Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- November 1, 2018
- Completion date
- June 30, 2019
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
incidence of cs scar infection